What is the best approach for screening a postmenopausal woman with a family history of ovarian cancer, specifically a affected cousin, who presents asymptomatic with an unremarkable physical exam?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Counseling and Symptom Education is the Recommended Approach

For this postmenopausal woman with a family history of ovarian cancer (one affected cousin), the correct answer is C: Counseling and asking about ovarian cancer symptoms. The USPSTF gives a Grade D recommendation (recommends against) screening for ovarian cancer in asymptomatic women, even those with a family history, because screening does not reduce mortality and causes significant harms 1, 2.

Why Not Screen with Pelvic Ultrasound or CA-125?

The evidence is unequivocal that routine screening fails to save lives:

  • No mortality benefit: The PLCO trial of 78,216 women (17% with family history of breast or ovarian cancer) showed no reduction in ovarian cancer deaths with annual CA-125 and transvaginal ultrasound screening (118 vs. 100 deaths; relative risk 1.18) 1, 2, 3
  • High false-positive rates: Approximately 10% of screened women receive false-positive results, with only 1-2% of positive tests representing actual cancer 1, 2, 3
  • Unnecessary surgeries: For every 10,000 women screened annually, 20-65 women without cancer undergo unnecessary surgery, with nearly 21 major complications per 100 surgical procedures 2, 3
  • No stage shift: The PLCO trial found no significant shift toward earlier stage detection with screening 3

The Correct Approach: Counseling and Symptom Awareness

Focus on educating the patient about ovarian cancer symptoms and when to seek evaluation 2, 4:

  • Key symptoms to discuss: Abdominal or pelvic pain, unexplained weight loss, bloating or increased abdominal size, and early satiety 2, 4
  • Emphasize that early-stage disease is usually asymptomatic, so symptom awareness targets more advanced disease but is still the recommended approach over screening 2

Assess Need for Genetic Counseling

One affected cousin alone does not meet high-risk criteria, but you should assess the complete family history 1, 2:

  • High-risk family history requiring genetic counseling referral: Two or more first- or second-degree relatives with ovarian cancer, or a combination of breast and ovarian cancer 1, 2, 5
  • For Ashkenazi Jewish women: One first-degree relative or two second-degree relatives on the same side with breast or ovarian cancer 1, 2, 5
  • If genetic counseling reveals BRCA1/BRCA2 or Lynch syndrome mutations, management changes entirely with consideration of risk-reducing bilateral salpingo-oophorectomy 2, 3, 5

Discuss Risk-Reduction Strategies

Counsel about proven protective factors 1, 2, 5:

  • Oral contraceptive use: Reduces ovarian cancer risk by approximately 50% 2, 3, 5
  • Other protective factors: Pregnancy, breastfeeding, and bilateral tubal ligation 1, 2, 5

Common Pitfall to Avoid

Do not order CA-125 or pelvic ultrasound as screening tests in this asymptomatic woman. While these tests may be appropriate for evaluating concerning symptoms, using them for screening in average-risk or moderately increased-risk women (like this patient with one affected cousin) leads to more harm than benefit through false-positives and unnecessary interventions 1, 2.

Why Not CEA (Option D)?

Carcinoembryonic antigen (CEA) has no role in ovarian cancer screening or diagnosis—it is a tumor marker for colorectal and other gastrointestinal malignancies, not ovarian cancer [@general medical knowledge@].

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Ovarian Cancer Screening Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Postmenopausal Women with Family History of Ovarian Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and Management of Ovarian Cancer.

American family physician, 2016

Guideline

Genetic Counseling for Ovarian Cancer Risk Assessment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the most appropriate next step in managing a 55-year-old postmenopausal woman with a family history of ovarian cancer and no known genetic testing?
What is the most appropriate initial step in managing a postmenopausal woman with a family history of ovarian cancer who is asymptomatic and has no known genetic testing?
What is the best initial screening approach for an asymptomatic postmenopausal woman with a family history of ovarian cancer?
What is the recommended screening approach for a postmenopausal woman with a family history of ovarian cancer?
What is the most appropriate initial step in managing an asymptomatic patient with a family history of ovarian cancer and no known genetic testing?
What is the best approach to manage burning mouth syndrome in a middle-aged to elderly woman?
What is the recommended dosage of Pulmocare (nutritional supplement) for a patient with multidrug-resistant tuberculosis (MDR-TB)?
What is the best management approach for an adult or child with a history of hematopoietic stem cell transplantation (HSCT) presenting with gut Graft-Versus-Host Disease (GVHD) and metabolic acidosis?
What is the better choice between Pulmocare (nutritional supplement) and Geriaplus (nutritional supplement) for a patient with multidrug-resistant tuberculosis (MDR-TB)?
What is the most appropriate initial health strategy for a 1-year married female patient with a body mass index (BMI) of 48, seeking to improve her chances of conception, after being advised to lose weight?
What is the risk of Systemic Lupus Erythematosus (SLE) in a daughter with a family history of autoimmune thyroid disease in her mother?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.